In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MATFIX CLASS I RECALL OF LIFEDEFENSE PLUS DEFIBRILLATOR/MONITOR/PACER

This article was originally published in The Gray Sheet

Executive Summary

MATFIX CLASS I RECALL OF LIFEDEFENSE PLUS DEFIBRILLATOR/MONITOR/PACER is more than 50% complete, the firm says. Of the 656 units affected by the July 6 recall, 366 units distributed in the United States already have been returned. Matrx expects that approximately 150 additional units sold in the U.S. will be returned to the firm within a month. The remaining devices, which were distributed to Europe, South America, and the Pacific Rim, are on target to be returned by a February deadline, according to the company.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002917

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel